Reactogenicity and immunogenicity of the intradermal administration of BNT162b2 mRNA vaccine in healthy adults who were primed with an inactivated SARS-CoV-2 vaccine

Reactogenicity and immunogenicity of the intradermal administration of BNT162b2 mRNA vaccine in healthy adults who were primed with an inactivated SARS-CoV-2 vaccine

Because of the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), safe and effective vaccines are urgently required. The shortage of effective vaccines is a major challenge in many developing countries. We studied intradermal (ID) fractional dose BNT162b2 mRNA (Comirnaty®, Pfi...

Full description

Bibliographic Details
Main Authors: Yutthapong Temtanakitpaisan, Suchaorn Saengnipanthkul, Nataporn Sarakosol, Sasinapa Maskasame, Siwawoot Mongkon, Benjaporn Buranrat, Sutthiwan Thammawat, Samadhi Patamatamkul, Pattaranit Nernsai
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Vaccine: X
Subjects:
SARS-CoV-2
COVID-19 vaccines
Neutralizing antibodies
Intradermal
Immunity
Online Access:http://www.sciencedirect.com/science/article/pii/S2590136222001024

Internet

http://www.sciencedirect.com/science/article/pii/S2590136222001024

Similar Items